PepVault
/ database / GLP-1 Agonist

Dulaglutide

Also: Trulicity

Weekly GLP-1 with cardiovascular outcome data in T2D.

Evidence
established
Legal status
rx only
Half-life
~5 days
Routes
subq
View on Limitless LifeAdd to compare
What it is

Dulaglutide is a fusion of two GLP-1 analogs to a human IgG4 Fc fragment, giving it a long half-life suitable for once-weekly dosing. Primarily approved for type 2 diabetes.

Mechanism

Long-acting GLP-1 fusion protein — weekly dosing.

Outcomes it's matched to
Safety

Nausea on titration; well-tolerated long term.

  • MTC history
  • MEN2
Legal context

FDA-approved for T2D.

1:1 GUIDANCE

Have questions about this peptide?

Get free 1:1 guidance from a peptide professional before you start. They'll help you think through dosing, stacking, and whether this fits your goals.

REQUEST A CALL →
PepVault

An outcome-driven reference for modern peptides. Educational only — not medical advice, not a sales platform, not affiliated with any clinic.

Disclaimer: PepVault is an educational resource. Nothing on this site is medical advice. Many peptides discussed are research compounds and are not approved by the FDA or equivalent agencies. Always consult a qualified clinician before starting any protocol.

© 2026 PepVault